Neuralink's 'Blindsight' Brain Implant Receives FDA Breakthrough Designation

The device aims to restore vision to the blind, including those born without sight, by directly stimulating the visual cortex.

Neuralink's Blindsight implant has been granted 'breakthrough device' status by the FDA, expediting its development and review.
The implant is designed to enable vision for individuals who have lost their eyes and optic nerve, or were born blind, by bypassing traditional visual pathways.
Initial vision quality will be low resolution, similar to old video game graphics, but may eventually surpass natural human vision.
The device works by stimulating the visual cortex with electrical signals, potentially allowing users to see in infrared, ultraviolet, or even radar wavelengths.
Neuralink has previously tested brain chips for other applications, including enabling paralyzed patients to control digital devices with their thoughts.